The health benefits of marijuana are widely discussed and debated. A company has come up with a cannabis inhaler which can be used by patients in need.
The use of marijuana as a medicinal herb is becoming widely popular. This is mainly because of the growing research around marijuana and its medicinal properties. According to WebMD, the herb can be used to treat a number of conditions including cancer, Alzheimer's disease, muscle spasms, etc.
Though there is no evidence that it is beneficial for many conditions, Marcel Bonn-Miller, Ph.D., a substance abuse specialist at the University of Pennsylvania Perelman School of Medicine, says "The greatest amount of evidence for the therapeutic effects of cannabis relate to its ability to reduce chronic pain, nausea and vomiting due to chemotherapy, and spasticity [tight or stiff muscles] from MS." Though there are debates surrounding research evidence and legalization, about 33 states in the US have already legalized the use of medicinal marijuana.
Taking the benefits of marijuana into account, an Israeli pharma-tech company called Syqe Medical has announced the creation of the first ever cannabis inhaler. According to The Algemeiner, the product was developed after an investment of $83 million and about 8 years of clinical trials. It had undergone various regulatory screening processes before its approval for distribution. The company that was given the permit to import medicinal cannabis for research purposes imported the herb from the Dutch company Bedrocan.
The unique technology of the inhaler allows individuals to take the prescribed dosages of cannabis. The metered dose inhaler will be used by doctors for medicinal purposes. The company says that it "provides symptom relief in minutes," and its "unprecedented dosing precision achieves maximum relief while avoiding any undesired psychoactive effects." The pocket-sized product will also be easy to use and carry.
The product which has already been approved by the country’s Minister of Health will be out in the market soon. The company has decided to begin its initial distribution in the country before exporting to other countries. It will be made available to licensed patients for $545. The inhaler will be delivered at the footsteps of the customers and therefore it may not be accessible to many.
According to Israel National News, Perry Davidson, the founder of the company said, "Almost 80% of cannabis patients inhale the plant. For too long, physicians who wish to treat these patients have been without the most basic clinical knowledge on dosing, efficacy and adverse events of cannabis. For 8 years, Syqe has been developing proprietary technologies for the administration of raw plants, and through our clinical trials, we were able to determine the recommended dosage of inhaled cannabis down to the microgram. This launch marks the beginning of a new chapter in pain treatment, one in which physicians can confidently prescribe precise dosages of cannabis."
Israeli scientists made cannabis inhalers to help alleviate pain caused by cancer and to deliver medicinal benefits to individuals with respiratory issues like asthma. This technology is a breakthrough in the medical world and may be beneficial for people suffering from serious health conditions.